Injectable Silk-Based Filler
Aesthetic soft tissue augmentation (e.g., facial wrinkles, volume loss)
DevelopmentActive
Key Facts
Indication
Aesthetic soft tissue augmentation (e.g., facial wrinkles, volume loss)
Phase
Development
Status
Active
Company
About Sofregen Medical
Sofregen Medical is a private biotechnology company leveraging a proprietary silk protein platform to create a portfolio of implantable and injectable biomaterials for soft tissue regeneration. Founded in 2013 and headquartered in Medford, Massachusetts, the company has two FDA-cleared products: SERI® Surgical Scaffold and Silk Voice® Injectable Implant. Sofregen is advancing its pipeline to develop next-generation silk-based fillers and devices for the aesthetic and reconstructive surgery markets, aiming to become a leader in regenerative beauty solutions.
View full company profile